Source link : https://www.newshealth.biz/health-news/nice-backs-new-drug-combo-for-acute-lymphoblastic-leukaemia/
The National Institute for Health and Care Excellence (NICE) has recommended blinatumomab (Blincyto, Amgen) with chemotherapy for NHS use in adults with aggressive leukaemia. The combination therapy is now an option for patients with Philadelphia-chromosome-negative, CD19-positive B-cell precursor acute lymphoblastic leukaemia (ALL), even if they have no detectable minimal residual disease (MRD) at the start […]
Author : News Health
Publish date : 2025-02-24 18:37:57
Copyright for syndicated content belongs to the linked Source.